Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2014
03/06/2014WO2014036495A2 Diagnostic assays and kits for detection of folate receptor 1
03/06/2014WO2014036484A1 Self-powered blood coagulation chip for inr value and hematocrit determination
03/06/2014WO2014036483A1 Methods and compositions for detecting drusen and predicting age-related macular degeneration
03/06/2014WO2014036440A2 Papp-a2 as a marker for monitoring, predicting and diagnosing preeclampsia
03/06/2014WO2014036357A1 Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)
03/06/2014WO2014036312A2 Immunosignaturing: a path to early diagnosis and health monitoring
03/06/2014WO2014036183A2 Biochemical markers of red blood cell storage and toxicity
03/06/2014WO2014036182A2 Diagnosis and treatment of autism spectrum disorder
03/06/2014WO2014036175A1 Modifying a sensitivity value to adjust for lag between in vivo sensor analyte values and an in vitro reference analyte value
03/06/2014WO2014036110A2 System and method for testing engine lubricants
03/06/2014WO2014036088A1 Breath alcohol detection devices attached to mobile devices and in communication with mobile applications, and method of manufacturing and using the same
03/06/2014WO2014036077A1 Method for reconstructing the total organic carbon content from compositional modeling analysis
03/06/2014WO2014036040A2 Methods for diagnosis, prognosis and methods of treatment
03/06/2014WO2014035986A1 Method and kit for purifying nucleic acids
03/06/2014WO2014035979A1 Two-dimensional magnetic trap arrays for droplet control
03/06/2014WO2014035798A1 Silk lyogels for sustained release of protein therapeutics and methods of making and uses
03/06/2014WO2014035767A1 Method of using a handheld characteristic analyzer
03/06/2014WO2014035668A1 Functional assay for cancer recurrence and malignant potential
03/06/2014WO2014035663A1 Method and apparatus for testing coal coking properties
03/06/2014WO2014035333A1 Solid supported artificial cell membrane system
03/06/2014WO2014035039A1 Gene transcription analysis method using surface plasmon resonance sensor
03/06/2014WO2014034908A1 Sample testing device
03/06/2014WO2014034798A1 Method for detection of cancer, diagnostic drug and diagnostic kit for cancer, and pharmaceutical composition for treatment of cancer
03/06/2014WO2014034700A1 CELL PROLIFERATION REGULATION COMPOSITION CONTAINING PEPTIDE COMPRISING PARTIAL AMINO ACID SEQUENCE FOR BBF2H7 (BBF2 human homologue on chromosome7) OR ANTIBODY CAPABLE OF BINDING TO SAID PEPTIDE
03/06/2014WO2014034685A1 Diagnosis of rheumatoid arthritis by microrna
03/06/2014WO2014034667A1 Particulate water-absorbing agent and process for producing same
03/06/2014WO2014034577A1 Compound design device, compound design method, and computer program
03/06/2014WO2014034563A1 Composition comprising light-emitting compound exhibiting afterglow
03/06/2014WO2014034348A1 Heterocyclic compound, metal complex and fluorescent probe
03/06/2014WO2014034275A1 Nucleic acid analysis device
03/06/2014WO2014034168A1 Evaluation marker for early-stage renal disorder, and method for measuring said evaluation marker
03/06/2014WO2014034127A1 Binding/neutralizing human monoclonal antibodies against botulinum neurotoxin type b
03/06/2014WO2014033928A1 Material organization predict device, product fabrication method, and material organization predict method
03/06/2014WO2014033615A1 TROPONIN I (TnI) AS A SUITABLE MARKER PROTEIN FOR THE DETERMINATION OF ANIMAL SPECIES ORIGIN OF ADIPOSE TISSUE
03/06/2014WO2014033610A1 White blood cell monitoring during treatment cycles
03/06/2014WO2014033555A2 Sample collection devices comprising controls
03/06/2014WO2014033480A1 Histamine 4 receptor partial agonists, inverse agonists or antagonists for use|in treating non-autoimmune uveitis
03/06/2014WO2014033410A1 Method for determining the energy required to destabilise the conformation of a protein
03/06/2014WO2014033367A1 Method of selecting individualized brain cancer therapy
03/06/2014WO2014033329A1 On chip control of fluids using electrodes
03/06/2014WO2014033265A1 Method of calibration in a process of determining the content of a plurality of compounds contained in a drilling fluid
03/06/2014WO2014033262A1 Therapeutic and diagnostic mirna regulator in kidney disease
03/06/2014WO2014033258A1 Glycated haemoglobin assay method
03/06/2014WO2014033208A1 A method for obtaining blood plasma from a whole blood sample
03/06/2014WO2014033149A1 Marker vaccine
03/06/2014WO2014033145A1 Processing data obtained by operating a liquid treatment system
03/06/2014WO2014033009A1 Cell selection method and cells obtained therefrom
03/06/2014WO2014032793A1 Opto-electronic sensor
03/06/2014WO2014032737A1 Senescence tracers
03/06/2014WO2014032396A1 Microfluidic chip and application thereof
03/06/2014WO2014032175A1 Chromogenic absorbent material for animal litter and related chromogenic solution
03/06/2014WO2014018899A9 Electric measurement of monolayers following pro-cleave detection of presence and activity of enzymes and other target analytes
03/06/2014WO2014009808A3 Lipidated peptides as anti-obesity agents
03/06/2014WO2014006561A3 Method and devices for detecting macroions in a liquid medium
03/06/2014WO2014002115A3 A system and a method for measurement of adsorption isotherms and kinetics of hydrocarbons
03/06/2014WO2013179279A3 Method and device for analyzing biological samples
03/06/2014WO2013179062A3 Assays
03/06/2014WO2013151756A9 Electrodes for sensing chemical composition
03/06/2014WO2013132347A3 Improved elisa immunoassay for calprotectin
03/06/2014WO2012088479A3 Composition to overcome inhibitors in pcr and growth cultures
03/06/2014US20140068794 R2R1/2 In Diagnosis and Therapy
03/06/2014US20140067308 Automated System and Method for Monitoring Chromatography Column Performance, and Applications Thereof
03/06/2014US20140067307 Method of Calibration Intended to Be Used in A Process of Determining The Content of A Plurality of Compounds Contained in A Drilling Fluid
03/06/2014US20140066817 Method and System for Preventing Virus-Related Obesity and Obesity Related Diseases
03/06/2014US20140066623 Ribosome Structure and Protein Synthesis Inhibitors
03/06/2014US20140066606 Production of high mannose glycosylated proteins stored in the plastid of microalgae
03/06/2014US20140066464 Methods of diagnosing and treating cancer
03/06/2014US20140066431 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture
03/06/2014US20140066393 Method of selecting cancer patients for anti-angiogenesis therapy in combination with chemotherapy
03/06/2014US20140066387 Functionalized biomaterials for tissue regeneration
03/06/2014US20140066360 Methods for using semaphorin polypeptides
03/06/2014US20140066331 Ps-spcl searching apparatus and method using surface plasmon resonance
03/06/2014US20140066329 Lung cancer diagnostic assay
03/06/2014US20140066328 PREDICTING GASTROENTEROPANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NENs)
03/06/2014US20140066325 Protein Biomarkers for the Diagnosis of Prostate Cancer
03/06/2014US20140065727 Method for stabilizing protein
03/06/2014US20140065726 Latex particle for measurement reagent, coated latex particle, and measurement reagent for immunoturbidimetric method
03/06/2014US20140065724 Method of prognosing and diagnosing hereditary spastic paraplegia, mutant nucleic acid molecules and polypeptides
03/06/2014US20140065723 Enrichment and purification of infectious prion protein
03/06/2014US20140065722 Methods and Compositions for Highly Sensitive Detection of Molecules
03/06/2014US20140065714 Method of identifying glycated protein in sample and device for the glycated protein
03/06/2014US20140065712 Rapid detection of urea in adulterated milk using thread based microfluidic system
03/06/2014US20140065665 Method and System for Analyzing a Blood Sample
03/06/2014US20140065660 Microfluidic biological barrier model and associated method
03/06/2014US20140065659 Culture method, group of mature adipocytes, drug screening method
03/06/2014US20140065656 Specimen imaging device and methods for use thereof
03/06/2014US20140065655 Screening method for substance acting on maintenance of epithelial properties of cell
03/06/2014US20140065651 Destructible surfactants and uses thereof
03/06/2014US20140065648 Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure
03/06/2014US20140065647 System and method for spatiotemporally analyzed rapid assays
03/06/2014US20140065646 Assay system
03/06/2014US20140065644 Method of therapy
03/06/2014US20140065643 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
03/06/2014US20140065642 Systems and methods for characterization of molecules
03/06/2014US20140065641 Method of measuring the degree of non-inflammatory stress response
03/06/2014US20140065638 Methods and Compositions for Measuring Cell Permeability
03/06/2014US20140065636 Methods for measuring concentrations of biomolecules
03/06/2014US20140065635 Prognostic tests for development of dermal stretch marks and implications for the preventative treatment thereof
03/06/2014US20140065633 Methods for determining the effects of compounds on jak/stat activity
03/06/2014US20140065619 MARKER SET OF HIF-1alpha, HDAC3 AND WDR5 FOR PREDICTING METASTASIS AND SURVIVAL OF CANCERS
1 ... 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 ... 3937